Regeneron Announces New Investment in Manufacturing of its Industry-Leading Biologic Medicines
April 22, 2025
Regeneron’s ongoing and planned investments in New York and North Carolina infrastructure and manufacturing expected to total more than $7 billion Regeneron Pharmaceuticals, Inc. announced